-The Hindu Whichever way one looks at the data, there is nothing much to crow about the 68th round of survey Whichever way one looks at the key indicators of employment and unemployment released by the National Sample Survey Office (NSSO) recently, there is nothing much to crow about in inferences that can be drawn from the data collected in the 68th round of survey conducted during the period July 2011 to...

-Reuters India has launched a wide-ranging surveillance programme that will give its security agencies and even income tax officials the ability to tap directly into e-mails and phone calls without oversight by courts or parliament, several sources said. The expanded surveillance in the world's most populous democracy, which the government says will help safeguard national security, has alarmed privacy advocates at a time when allegations of massive US digital snooping beyond American...

-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...

-Outlook As the Manmohan Singh government makes evident its unfriendliness to villages, the nation hurtles towards disaster. It's a danger no one wants to face. Prime Minister Manmohan Singh has been trying for years to make us believe that agriculture is a vast marshland in which a huge population is stuck ankle- to neck-deep and it is his duty to rescue them. "Our salvation lies in moving people out of agriculture," he...

-The Economic Times MUMBAI: The United States Food and Drug Administration (USFDA), widely considered the world's most stringent regulatory authority, has said India's share in generic exports to the US over the years is an indication of the good manufacturing norms practised by Indian drugmakers. As the Ranbaxy scandal threatens to tarnish India's image as a hub of manufacturing world-class generic drugs, the statement, by USFDA's spokesman Chris Kelly in an...